Menu
  • Join
  • Login
  • Contact
 

Search abstracts


LIPID BLEND NANOCARRIER SCAFFOLD FOR ORAL BIOAVAILABILITY ENHANCEMENT OF EXEMESTANE

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: SINGH, Archu (Jamia Hamdard, Jamia Hamdard, India)
  • Co-author(s): Archu Singh: Pharmaceutics, Jamia Hamdard, New Delhi, India
    Kanchan Kohli: Pharmaceutics, Jamia Hamdard, New Delhi, India
  • Abstract:

    Background

    Exemestane (EXE) is a novel oral steroidal aromatase inhibitor, approved for the treatment of breast cancer. However, its oral clinical application is limited because of low aqueous solubility and low oral bioavailability.

    Methods

    EXE loaded NLCs were using Precirol® ATO5 and Flaxseed as the solid lipid and liquid lipid respectively by

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses